267 related articles for article (PubMed ID: 19675782)
1. Premature ejaculation.
McMahon CG
Indian J Urol; 2007 Apr; 23(2):97-108. PubMed ID: 19675782
[TBL] [Abstract][Full Text] [Related]
2. New agents in the treatment of premature ejaculation.
McMahon CG; McMahon CN; Leow LJ
Neuropsychiatr Dis Treat; 2006 Dec; 2(4):489-503. PubMed ID: 19412497
[TBL] [Abstract][Full Text] [Related]
3. The etiology and management of premature ejaculation.
McMahon CG
Nat Clin Pract Urol; 2005 Sep; 2(9):426-33. PubMed ID: 16474680
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of dapoxetine in the treatment of premature ejaculation.
McMahon CG
Clin Med Insights Reprod Health; 2011 Aug; 5():25-39. PubMed ID: 24453509
[TBL] [Abstract][Full Text] [Related]
5. Interventions to treat premature ejaculation: a systematic review short report.
Cooper K; Martyn-St James M; Kaltenthaler E; Dickinson K; Cantrell A
Health Technol Assess; 2015 Mar; 19(21):1-180, v-vi. PubMed ID: 25768099
[TBL] [Abstract][Full Text] [Related]
6. Oral agents for the treatment of premature ejaculation: review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation.
McMahon CG; Porst H
J Sex Med; 2011 Oct; 8(10):2707-25. PubMed ID: 21771283
[TBL] [Abstract][Full Text] [Related]
7. Premature ejaculation: bother and intravaginal ejaculatory latency time in Iran.
Zargooshi J
J Sex Med; 2009 Dec; 6(12):3478-89. PubMed ID: 19732308
[TBL] [Abstract][Full Text] [Related]
8. A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation.
Hutchinson K; Cruickshank K; Wylie K
Drug Saf; 2012 May; 35(5):359-72. PubMed ID: 22452563
[TBL] [Abstract][Full Text] [Related]
9. Dapoxetine: a new option in the medical management of premature ejaculation.
McMahon CG
Ther Adv Urol; 2012 Oct; 4(5):233-51. PubMed ID: 23024705
[TBL] [Abstract][Full Text] [Related]
10. Dapoxetine for premature ejaculation.
McMahon CG
Expert Opin Pharmacother; 2010 Jul; 11(10):1741-52. PubMed ID: 20540653
[TBL] [Abstract][Full Text] [Related]
11. Dapoxetine: an evidence-based review of its effectiveness in treatment of premature ejaculation.
McCarty E; Dinsmore W
Core Evid; 2012; 7():1-14. PubMed ID: 22315582
[TBL] [Abstract][Full Text] [Related]
12. Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine.
Shabsigh R; Patrick DL; Rowland DL; Bull SA; Tesfaye F; Rothman M
BJU Int; 2008 Sep; 102(7):824-8. PubMed ID: 18647300
[TBL] [Abstract][Full Text] [Related]
13. Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine.
McMahon C; Kim SW; Park NC; Chang CP; Rivas D; Tesfaye F; Rothman M; Aquilina J;
J Sex Med; 2010 Jan; 7(1 Pt 1):256-68. PubMed ID: 19878447
[TBL] [Abstract][Full Text] [Related]
14. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study.
Dinsmore WW; Wyllie MG
BJU Int; 2009 Apr; 103(7):940-9. PubMed ID: 19245438
[TBL] [Abstract][Full Text] [Related]
15. Comparison between on-demand dosing of dapoxetine alone and dapoxetine plus mirodenafil in patients with lifelong premature ejaculation: prospective, randomized, double-blind, placebo-controlled, multicenter study.
Lee WK; Lee SH; Cho ST; Lee YS; Oh CY; Yoo C; Cho JS; Lee SK; Yang DY
J Sex Med; 2013 Nov; 10(11):2832-41. PubMed ID: 23937271
[TBL] [Abstract][Full Text] [Related]
16. Premature ejaculation and pharmaceutical company-based medicine: the dapoxetine case.
Waldinger MD; Schweitzer DH
J Sex Med; 2008 Apr; 5(4):966-997. PubMed ID: 18371047
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy for premature ejaculation.
Waldinger MD
Expert Opin Pharmacother; 2015; 16(17):2615-24. PubMed ID: 26579971
[TBL] [Abstract][Full Text] [Related]
18. Improved ejaculatory latency, control and sexual satisfaction when PSD502 is applied topically in men with premature ejaculation: results of a phase III, double-blind, placebo-controlled study.
Carson C; Wyllie M
J Sex Med; 2010 Sep; 7(9):3179-89. PubMed ID: 20584124
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study.
McMahon CG; Giuliano F; Dean J; Hellstrom WJ; Bull S; Tesfaye F; Sharma O; Rivas DA; Aquilina JW
J Sex Med; 2013 Sep; 10(9):2312-25. PubMed ID: 23845016
[TBL] [Abstract][Full Text] [Related]
20. Emerging treatments for premature ejaculation: focus on dapoxetine.
Hellstrom WJ
Neuropsychiatr Dis Treat; 2009; 5():37-46. PubMed ID: 19557098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
